Cite
HARVARD Citation
Kent, S. et al. (n.d.). The 5‐lipoxygenase‐activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma. Clinical & experimental allergy. 43 (2), pp. 177-186. [Online].